Danaher, the NYSE-listed biotechnology and diagnostics company, is to acquire Masimo Corporation, the California-based firm best known for its development of optical pulse oximetry devices widely used ...

Danaher Corp. agreed to buy Masimo Corp., in a deal with an enterprise value of about $9.9 billion, allowing it to gain a foothold in the medical supply business. Danaher will pay $180 per share in ...

Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...

Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended January 3, 2026. Preliminary Fourth Quarter 2025 Financial Results: ...

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism, ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Masimo Corporation before investing. In this article, we go over a few key ...

Add Yahoo as a preferred source to see more of our stories on Google. Cover of Rainbow's 'The Temple of the King 1975-1976' (Edsel Records) A new box set dedicated to the early years of Ritchie ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Amid its multifront legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ground—including a significant patent infringement verdict in federal court, plus the ...